Flagship Ventures Fund V General Partner LLC - Sep 15, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
10%+ Owner
Signature
Flagship Ventures Fund V General Partner LLC, By: /s/ Noubar B. Afeyan, Name: Noubar B. Afeyan, Ph.D., Title: Manager
Stock symbol
CDAKQ
Transactions as of
Sep 15, 2022
Transactions value $
$0
Form type
4
Date filed
9/16/2022, 07:30 PM
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDAKQ Common Stock Purchase +723K +63.21% 1.87M Sep 15, 2022 By Flagship Ventures Fund V, L.P. F1, F2
transaction CDAKQ Common Stock Purchase +211K +21.54% 1.19M Sep 15, 2022 By Flagship V VentureLabs Rx Fund, L.P. F1, F3
holding CDAKQ Common Stock 486K Sep 15, 2022 Flagship VentureLabs V LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Warrants to purchase Common Stock Purchase +723K 723K Sep 15, 2022 Common Stock 723K $1.88 By Flagship Ventures Fund V, L.P. F1, F2
transaction CDAKQ Warrants to purchase Common Stock Purchase +211K 211K Sep 15, 2022 Common Stock 211K $1.88 By Flagship V VentureLabs Rx Fund, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2022, pursuant to an underwritten public offering by the Issuer (the "Offering"), Flagship Ventures Fund V, L.P. ("Flagship Fund V") acquired 722,590 shares of Common Stock and accompanying warrants to purchase 722,590 shares of Common Stock, and Flagship V VentureLabs Rx Fund, L.P. ("Flagship Fund V Rx") acquired 210,743 shares of Common Stock and accompanying warrants to purchase 210,743 shares of Common Stock. The combined purchase price in the Offering was $1.50 per share of Common Stock and accompanying warrant.
F2 Shares held by Flagship Fund V. Flagship Ventures Fund V General Partner LLC ("Flagship V GP") is the general partner of Flagship Fund V. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship V GP. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
F3 Shares held by Flagship Fund V Rx. Flagship V GP is the general partner of Flagship Fund V Rx. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship V GP. Each of the reporting persons except for Flagship Fund V Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
F4 Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") is the manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. Noubar B. Afeyan, Ph.D. is the CEO and sole stockholder of Flagship Pioneering. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.